Last quarter (Q4 2023), Barinthus Biotherapeutics's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q4, Barinthus Biotherapeutics's net income was $-45.47M. See Barinthus Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 7.26M	$ 802.00K	$ 44.70M	$ 268.00K	$ 4.82M	$ 6.85M
Cost of Revenue	-	-	-	-	-	-
Gross Profit	$ 7.26M	$ 802.00K	$ 44.70M	$ 268.00K	-	-
Operating Expense	$ 36.12M	$ 84.72M	$ -48.74M	$ -45.49M	$ 21.59M	$ 29.53M
Operating Income	$ -67.59M	$ -83.91M	$ -4.04M	$ -45.22M	$ -16.77M	$ -22.69M
Net Non Operating Interest Income Expense	$ 5.29M	$ 2.85M	$ 4.32M	$ 1.33M	$ -3.60M	$ -92.55K
Other Income Expense	$ -3.63M	$ -4.54M	$ -567.00K	$ 7.46M	$ 2.53M	$ 83.45K
Pretax Income	$ -84.99M	$ -76.52M	$ 850.00K	$ -51.14M	$ -17.84M	$ -22.70M
Tax Provision	$ -4.49M	$ -3.08M	$ -4.47M	$ -28.00K	$ 95.00K	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -108.64M	$ -73.35M	$ 5.34M	$ -50.87M	$ -17.71M	$ -20.73M
Basic EPS	$ -1.50	$ -1.91	-	$ -1.96	$ -371.62	$ -455.25
Diluted EPS	$ -1.49	$ -1.91	-	$ -1.96	$ -371.62	$ -455.25
Basic Average Shares	$ 113.85M	$ 38.39M	-	$ 25.89M	$ 47.65K	$ 45.53K
Diluted Average Shares	$ 114.77M	$ 38.39M	-	$ 25.89M	$ 47.65K	$ 45.53K
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 36.12M	$ 84.72M	$ -48.74M	$ -45.49M	$ 21.59M	$ 29.53M
Net Income From Continuing And Discontinued Operation	$ -80.51M	$ -73.35M	$ 5.34M	$ -50.87M	$ -17.71M	$ -20.73M
Normalized Income	$ -45.03M	$ -79.60M	-	-	$ -19.72M	$ -20.73M
Interest Expense	-	-	-	-	$ 3.60M	$ 132.75K
EBIT	$ -89.11M	$ -76.49M	$ 869.00K	$ -52.48M	$ -14.24M	$ -22.57M
EBITDA	$ -60.33M	$ -71.06M	$ 5.19M	$ -51.87M	$ -14.03M	$ -22.22M

Currency in USD

Barinthus Biotherapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing